BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22421948)

  • 21. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
    Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer in patients with type 2 diabetes mellitus: a single-center experience.
    Sinagra E; Guarnotta V; Raimondo D; Mocciaro F; Dolcimascolo S; Rizzolo CA; Puccia F; Maltese N; Citarrella R; Messina M; Spada M; Tomasello G; Cappello F; Leone A; Rossi F; Di Mitri R; Morreale GC; Marasà S; Midiri M; Midiri F; Sinagra D
    J Biol Regul Homeost Agents; 2017; 31(4):1101-1107. PubMed ID: 29254321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
    Fransgaard T; Thygesen LC; Gögenur I
    Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus and hyperglycemia control on the risk of colorectal adenomatous polyps: a retrospective cohort study.
    Budzynska K; Passerman D; White-Perkins D; Rees DA; Xu J; Lamerato L; Schooley S
    BMC Fam Pract; 2018 Aug; 19(1):145. PubMed ID: 30157768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
    Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
    Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.
    Ki YJ; Kim HJ; Kim MS; Park CM; Ko MJ; Seo YS; Moon SM; Choi JA
    Cancer Res Treat; 2017 Jan; 49(1):29-36. PubMed ID: 27384155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery.
    Liu XR; Liu F; Li ZW; Lv Q; Shu XP; Li LS; Tong Y; Zhang W; Peng D
    Nutr Cancer; 2023; 75(10):1926-1933. PubMed ID: 37870939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus.
    Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N
    Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
    Romero IL; McCormick A; McEwen KA; Park S; Karrison T; Yamada SD; Pannain S; Lengyel E
    Obstet Gynecol; 2012 Jan; 119(1):61-7. PubMed ID: 22183212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin usage and the risk of colorectal cancer: a national cohort study.
    Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
    Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
    J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer.
    Huang CW; Sun LC; Shih YL; Tsai HL; Chen CW; Yeh YS; Ma CJ; Huang CJ; Wang JY
    World J Surg Oncol; 2012 May; 10():76. PubMed ID: 22553992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
    Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
    Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and Colorectal Cancer - A Systematic Review.
    Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
    Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.